Hydroxycarbamide in children with sickle cell anaemia after first-dose vs. chronic therapy: pharmacokinetics and predictive models for drug exposure.
about
Hydroxycarbamide in children with sickle cell anaemia after first-dose vs. chronic therapy: pharmacokinetics and predictive models for drug exposure.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
Hydroxycarbamide in children w ...... tive models for drug exposure.
@en
Hydroxycarbamide in children w ...... tive models for drug exposure.
@nl
type
label
Hydroxycarbamide in children w ...... tive models for drug exposure.
@en
Hydroxycarbamide in children w ...... tive models for drug exposure.
@nl
prefLabel
Hydroxycarbamide in children w ...... tive models for drug exposure.
@en
Hydroxycarbamide in children w ...... tive models for drug exposure.
@nl
P2093
P2860
P356
P1476
Hydroxycarbamide in children w ...... ctive models for drug exposure
@en
P2093
Gregory Kearns
Guolian Kang
Joana Marie Mack
Joseph Moen
Julie A Panepinto
Kathleen A Neville
Paweł Wiczling
Robert Liem
Uttam Garg
P2860
P304
P356
10.1111/BCP.13426
P407
P577
2017-11-28T00:00:00Z